|
Volumn 35, Issue 6, 2003, Pages 2275-2277
|
Liver transplantation in hepatitis C virus-related cirrhosis
a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOTRANSFERASE;
HEPATITIS C ANTIBODY;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE;
TACROLIMUS;
ACUTE GRAFT REJECTION;
ADULT;
AMINOTRANSFERASE BLOOD LEVEL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG MEGADOSE;
FOLLOW UP;
GRAFT FAILURE;
GRAFT REJECTION;
HEPATITIS C VIRUS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER CIRRHOSIS;
LIVER FUNCTION TEST;
LIVER TRANSPLANTATION;
MAINTENANCE THERAPY;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RECIPIENT;
RECURRENT DISEASE;
REINFECTION;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
RISK FACTOR;
SURVIVAL RATE;
SURVIVAL TIME;
TIME SERIES ANALYSIS;
TREATMENT OUTCOME;
|
EID: 12444330371
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(03)00791-7 Document Type: Conference Paper |
Times cited : (4)
|
References (13)
|